BR112013030242A2 - método de tratamento de um distúrbio autoimune em um sujeito humano - Google Patents
método de tratamento de um distúrbio autoimune em um sujeito humanoInfo
- Publication number
- BR112013030242A2 BR112013030242A2 BR112013030242A BR112013030242A BR112013030242A2 BR 112013030242 A2 BR112013030242 A2 BR 112013030242A2 BR 112013030242 A BR112013030242 A BR 112013030242A BR 112013030242 A BR112013030242 A BR 112013030242A BR 112013030242 A2 BR112013030242 A2 BR 112013030242A2
- Authority
- BR
- Brazil
- Prior art keywords
- treating
- human subject
- autoimmune disorder
- autoimmune
- disorder
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
- C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
- C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/94—Stability, e.g. half-life, pH, temperature or enzyme-resistance
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Transplantation (AREA)
- Dermatology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161489949P | 2011-05-25 | 2011-05-25 | |
PCT/US2012/039098 WO2012162367A1 (en) | 2011-05-25 | 2012-05-23 | Methods of treating systemic lupus erythematosus, scleroderma, and myositis with an antibody against interferon-alpha |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112013030242A2 true BR112013030242A2 (pt) | 2016-12-06 |
Family
ID=47217695
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112013030242A BR112013030242A2 (pt) | 2011-05-25 | 2012-05-23 | método de tratamento de um distúrbio autoimune em um sujeito humano |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP2714080A4 (pt) |
JP (1) | JP2014516970A (pt) |
KR (1) | KR20140043402A (pt) |
CN (1) | CN103732251A (pt) |
BR (1) | BR112013030242A2 (pt) |
CA (1) | CA2836926A1 (pt) |
MX (1) | MX2013013785A (pt) |
RU (1) | RU2013157177A (pt) |
WO (1) | WO2012162367A1 (pt) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2791170A1 (en) | 2011-12-16 | 2014-10-22 | Synthon Biopharmaceuticals B.V. | Compounds and methods for treating inflammatory diseases |
WO2013101771A2 (en) * | 2011-12-30 | 2013-07-04 | Genentech, Inc. | Compositions and method for treating autoimmune diseases |
ES2745103T3 (es) * | 2013-06-15 | 2020-02-27 | Tocagen Inc | Partículas inmunosupresivas similares a virus basadas en gammaretrovirus |
CN103740755A (zh) * | 2013-12-23 | 2014-04-23 | 中国农业大学 | 猪ifit1基因在抗prrs病毒中的应用 |
RU2580301C1 (ru) * | 2015-04-21 | 2016-04-10 | Людмила Николаевна Хон | Способ лечения системной красной волчанки человека |
CN107058521B (zh) * | 2017-03-17 | 2019-12-27 | 中国科学院北京基因组研究所 | 一种检测人体免疫状态的检测*** |
WO2020074723A1 (en) * | 2018-10-11 | 2020-04-16 | Vivia Biotech Sl | A method for determining the efficacy of treatment with a combination of drugs in a subject diagnosed with a disease and a method for classifying the utility of drug combinations in treatment of said subject |
CN113692287A (zh) * | 2018-10-26 | 2021-11-23 | 詹森生物科技公司 | I型干扰素标记及使用方法 |
EP3947448A4 (en) * | 2019-04-04 | 2023-02-01 | Janssen Biotech, Inc. | METHOD FOR ADMINISTRATION OF AN ANTI-IFN-ALPHA/-OMEGA ANTIBODY |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7087726B2 (en) * | 2001-02-22 | 2006-08-08 | Genentech, Inc. | Anti-interferon-α antibodies |
AU2004299833B2 (en) * | 2003-12-10 | 2009-05-07 | E. R. Squibb & Sons, L.L.C. | Interferon alpha antibodies and their uses |
WO2007002543A2 (en) * | 2005-06-23 | 2007-01-04 | Medimmune, Inc. | Antibody formulations having optimized aggregation and fragmentation profiles |
WO2009061818A1 (en) * | 2007-11-05 | 2009-05-14 | Medimmune, Llc | Methods of treating scleroderma |
BRPI0912570B8 (pt) * | 2008-05-07 | 2021-05-25 | Argos Therapeutics Inc | anticorpo anti-ifn-alfa humanizado, ou um fragmento de ligação ao antígeno do mesmo, composição terapêutica e seus usos |
US20110256149A1 (en) * | 2008-10-09 | 2011-10-20 | Medimmune, Llc | Antibody formulation |
US20140056889A1 (en) * | 2011-04-26 | 2014-02-27 | Genentech, Inc. | Compositions and method for treating autoimmune diseases |
-
2012
- 2012-05-23 KR KR1020137033960A patent/KR20140043402A/ko not_active Application Discontinuation
- 2012-05-23 CN CN201280024982.7A patent/CN103732251A/zh active Pending
- 2012-05-23 JP JP2014512069A patent/JP2014516970A/ja active Pending
- 2012-05-23 MX MX2013013785A patent/MX2013013785A/es not_active Application Discontinuation
- 2012-05-23 CA CA2836926A patent/CA2836926A1/en not_active Abandoned
- 2012-05-23 EP EP12789521.7A patent/EP2714080A4/en not_active Withdrawn
- 2012-05-23 WO PCT/US2012/039098 patent/WO2012162367A1/en active Application Filing
- 2012-05-23 RU RU2013157177/15A patent/RU2013157177A/ru unknown
- 2012-05-23 BR BR112013030242A patent/BR112013030242A2/pt not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO2012162367A1 (en) | 2012-11-29 |
EP2714080A1 (en) | 2014-04-09 |
EP2714080A4 (en) | 2014-11-19 |
CA2836926A1 (en) | 2012-11-29 |
MX2013013785A (es) | 2014-07-28 |
KR20140043402A (ko) | 2014-04-09 |
CN103732251A (zh) | 2014-04-16 |
RU2013157177A (ru) | 2015-06-27 |
JP2014516970A (ja) | 2014-07-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112013030242A2 (pt) | método de tratamento de um distúrbio autoimune em um sujeito humano | |
HK1201608A1 (en) | Captcha provision method and program | |
GB2503623B (en) | A method for predicting a result of a treatment of keratinous fibers | |
EP2836924A4 (en) | METHOD AND DEVICE FOR INTELLECTUAL MODELING AND PREDICTION | |
BR112014004125A2 (pt) | dispositivo e método de processamento de imagem, e, programa | |
BR112013023993A2 (pt) | método e aparelho para fornecer interface gráfica de usuário | |
BR112013033633A2 (pt) | método de formação de um laminado elástico | |
EP2755547A4 (en) | SYSTEM AND METHOD FOR ASSESSING THE NETWORK SKIN FUNCTION | |
BR112014001973A2 (pt) | composto e método de tratamento do câncer em um sujeito | |
BR112013022931A2 (pt) | dispositivo receptor, método de recepção, e, programa | |
BR112014008913A2 (pt) | dispositivo de controle de ação, método de controle de ação de um dispositivo de controle de ção, programa, e, dispositivo de formação de imagem | |
BR112014011529A2 (pt) | dispositivo de tratamento de água e método de tratamento de água | |
BR112013022539A2 (pt) | dispositivo receptor, método de recepção, e, programa | |
GB201315890D0 (en) | Applicability determination program, failure prediction device and applicability determination method | |
BR112013022820A2 (pt) | método de tratamento | |
EP2733605A4 (en) | METHOD AND MANAGEMENT DEVICE FOR WEB PAGE APPLICATION PROGRAM | |
EP2915626A4 (en) | DEVICE AND METHOD FOR GENERATING A PROCESSING PROGRAM | |
BR112014002132A2 (pt) | dispositivo e método de processamento de imagem, e, programa | |
EP2725440A4 (en) | PREDICTION DEVICE, PREDICTION METHOD, AND PREDICTION PROGRAM | |
EP2766716A4 (en) | METHOD AND SYSTEMS FOR IMPLEMENTING BIOMETRIC FUNCTIONS | |
BR112013023142A2 (pt) | método de tratamento de cabelos | |
BR112014010507A2 (pt) | aparelho de formaçãode imagem, método para controlar o mesmo, e programa | |
BR112014006581A2 (pt) | dispositivo de desenho de aeronave, programa de desenho de aeronave, e método de desenho de aeronave | |
BR112014010688A2 (pt) | dispositivo, método e programa de processamento de imagem | |
ZA201401954B (en) | A composition and method for treating an autoimmune disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |